Consistent with this view, CRC in MAP patients displays a distinctive molecular fingerprint of somatic G:C to T:A transversions in tumor suppressors and/or oncogenes including the adenomatous polyposis coli (APC) and KRAS genes [4–6]. The gene discussed is APC; the disease is neoplasm.